Evidence map›Paper›PMID 25148517›Full record

SynthesisPloS one2014

The vaginal microbiota: what have we learned after a decade of molecular characterization?

Janneke H H M van de Wijgert, Hanneke Borgdorff, Rita Verhelst, Tania Crucitti, Suzanna Francis, Hans Verstraelen, Vicky Jespers

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02558179 (Prospective Multicenter Cross Sectional Study of the American International Biotechnology), which is not on this map. Cited by 252 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
252citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02558179 unknown statusnot on this mapstarted 2015, after this paper: background citation

Prospective Multicenter Cross Sectional Study of the American International Biotechnology (AIBiotech) Gynecologene Test for the Evaluation of Bacterial Vaginosis/Vaginitis in Symptomatic Women

Typeobservational_patient_registrySponsorAmerican International BiotechnologyRan2015 to 2018Enrolled300ConditionsVaginosis, Bacterial
3 · Its place in the literature

Who cites it

252 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Bacterial Load ofMicroorganisms · 2026
    Article
  18. Review
  19. Article
  20. Review

192 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Janneke H H M van de WijgertInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Hanneke BorgdorffAcademic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands.
Rita VerhelstInternational Centre for Reproductive Health, Ghent University Hospital, Ghent, Belgium.
Tania CrucittiPrince Leopold Institute of Tropical Medicine, Antwerp, Belgium.
Suzanna FrancisLondon School for Hygiene and Tropical Medicine, London, United Kingdom.
Hans VerstraelenDepartment of Obstetrics and Gynecology, Ghent University Hospital, Ghent, Belgium.
Vicky JespersPrince Leopold Institute of Tropical Medicine, Antwerp, Belgium.

Funding

Medical Research Council G1002369Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

We conducted a systematic review of the Medline database (U.S. National Library of Medicine, National Institutes of Health, Bethesda, MD, U.S.A) to determine if consistent molecular vaginal microbiota (VMB) composition patterns can be discerned after a decade of molecular testing, and to evaluate demographic, behavioral and clinical determinants of VMB compositions. Studies were eligible when published between 1 January 2008 and 15 November 2013, and if at least one molecular technique (sequencing, PCR, DNA fingerprinting, or DNA hybridization) was used to characterize the VMB. Sixty three eligible studies were identified. These studies have now conclusively shown that lactobacilli-dominated VMB are associated with a healthy vaginal micro-environment and that bacterial vaginosis (BV) is best described as a polybacterial dysbiosis. The extent of dysbiosis correlates well with Nugent score and vaginal pH but not with the other Amsel criteria. Lactobacillus crispatus is more beneficial than L. iners. Longitudinal studies have shown that a L. crispatus-dominated VMB is more likely to shift to a L. iners-dominated or mixed lactobacilli VMB than to full dysbiosis. Data on VMB determinants are scarce and inconsistent, but dysbiosis is consistently associated with HIV, human papillomavirus (HPV), and Trichomonas vaginalis infection. In contrast, vaginal colonization with Candida spp. is more common in women with a lactobacilli-dominated VMB than in women with dysbiosis. Cervicovaginal mucosal immune responses to molecular VMB compositions have not yet been properly characterized. Molecular techniques have now become more affordable, and we make a case for incorporating them into larger epidemiological studies to address knowledge gaps in etiology and pathogenesis of dysbiosis, associations of different dysbiotic states with clinical outcomes, and to evaluate interventions aimed at restoring and maintaining a lactobacilli-dominated VMB.

Indexed as

Microbial ConsortiaAdolescentAdultCluster AnalysisFemaleHumansMicrobiotaPregnancyVaginaVaginosis, Bacterial

Identifiers

PMID25148517
PMCPMC4141851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.